Skip to main content

New Products: Dec 5, 2008

Premium
Roche Applied Science said this week that it introduced the new xCELLigence RTCA MP instrument two weeks ago. In comparison with the xCELLigence RTCA SP, the new RTCA MP Instrument has a higher throughput capacity and it is more versatile, which enables application on a wider range of experimental set-ups, the company said.
 
The new system features six E-Plate 96 microtiter plates, as opposed to only one in the RTCA SP. Each E-Plate can be individually addressed in independent experiments, to allow a group of researchers to work simultaneously. According to Roche, the first systems have already been delivered to major pharmaceutical companies.
 
The xCELLigence technology features a micro-electronic biosensor built into each well of the standard 96-well E-Plate. A cell which has contact with the sensor changes the electrical impedance between the microelectrodes.
 
Each change in the cell's status — for example, changes in cell adhesion, cytotoxicity, cell proliferation, cell-cell interactions, and morphological changes — leads to changes in the impedance measurements, and can therefore be detected in real time. Labeling of the cells or the use of reporters is not necessary.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.